CDER New May 18, 2015

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

May 15, 2015


New and Generic Drug Approvals

May 14, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Bactroban mupirocin calcium Ointment;Nasal Glaxosmithkline Labeling Revision
Escitalopram Oxalate escitalopram oxalate Tablet; Oral Mylan Pharma Approval
Famvir famciclovir Tablet;Oral Novartis Manufacturing Change or Addition
Gilenya fingolimod Capsule;Oral Novartis Supplement
Isovue-128 iopamidol Injectable;Injection Bracco Manufacturing Change or Addition
Isovue-200 iopamidol Injectable;Injection Bracco Manufacturing Change or Addition
Isovue-250 iopamidol Injectable;Injection Bracco Manufacturing Change or Addition
Isovue-300 iopamidol Injectable;Injection Bracco Manufacturing Change or Addition
Isovue-370 iopamidol Injectable;Injection Bracco Manufacturing Change or Addition
Isovue-M 200 iopamidol Injectable;Injection Bracco Manufacturing Change or Addition
Isovue-M 300 iopamidol Injectable;Injection Bracco Manufacturing Change or Addition
Lamivudine; Zidovudine lamivudine; zidovudine Tablet; Oral Suspension Mylan Labs Manufacturing Change or Addition
Paricalcitol paricalcitol Solution;Intravenous Hospira Inc Manufacturing Change or Addition
Rufinamide rufinamide Tablet;Oral Glenmark Generics Tentative Approval
Sirturo bedaquiline fumarate Tablet;Oral Janssen Therap Labeling Revision
Treximet naproxen sodium; sumatriptan succinate Tablet;Oral Pernix Ireland Ltd Efficacy Supplement with Clinical Data to Support
Treximet naproxen sodium; sumatriptan succinate Tablet;Oral Pernix Ireland Ltd Labeling Revision

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New May 18, 2015"

Post a Comment